Member Info for Elartu

He's 71 years old Horsford. He could indeed be gone in 2 years.

http://tools.euroland.com/tools/PressReleases/GetPressRelease/?ID=3405526&lang=en-GB&companycode=services

2.1p - 2.11p. Recent buys are being shown as sells.

Hi Adrianz, it's not a dumb question at all but I can't see it being anything but TexRAD software underlying that Nvidia article. Imagine the lawsuit awaiting Future Processing were they to be working on such software for anyone but their client, Cambridge Computed Imaging, which, of course, is wholly owned by Feedback. Check out the links below and read up on the on-going project. The project has been running 10 years and they admit to gaining "experience in the analysis of medical images, as well as in working with complex and innovative research projects, where there is a strong connection between science and business." It's doubtful they would have had any such experience before CCI came along as they are software specialists not medical specialists. I can't see them throwing away their hard earned reputation pretending to have developed their own competing software. It's just not feasible in my opinion. https://www.future-processing.com/client/cambridge-computed-imaging-ltd/ https://www.future-processing.com/documents/cci_case_study.pdf

The Future Processing / Nvidia news is spreading. Polish neural networks can diagnose lung cancer. http://technologynews.site/2017/11/18/polish-neural-networks-can-diagnose-lung-cancer/

Glad you all liked the Nvidia article as much a I did. This is a major tie in and shows the absolute promise that TexRAD holds. For Nvidia to post the article they must hold TexRAD software in very high esteem. To top it all, I see that Fortune 500 have made Nvidia CEO, Jensen Huang, their Business Person of the Year. http://fortune.com/businessperson-of-the-year/jen-hsun-huang-1/

I liked this so much I read it twice. How AI Can Detect Lung Cancer from CT Scans https://blogs.nvidia.com/blog/2017/11/16/detect-cancer-from-ct-scans/ https://link.springer.com/chapter/10.1007/978-3-319-68548-9_29

...but not by me unfortunately. 359,686 at 2.0594p.

Sell at 2.075p (up to 250k) - buy at 2.07p (up to 100k) and 2.1p (up to 250k). I don't know, I go away for a few days and prices are all over the place. What's going on guys?

I can't even get a quote to sell. The quote to buy is 2.175p which makes the only trade so far today a buy. Still away from home so not around much for now. Back tomorrow so expect longer posts then if there's anything going on.

Hi Horsford, not at home and with limited internet usage. Just looked at the two 900k trades and look like a rollover to me. If they aren't I'd be inclined to say they were buys but gut tells me it is just a rollover.

"A delegation of 12 UK based innovative companies in oncology will take part in India-UK Healthcare Leadership Forum to be held in Mumbai on November 13. The delegation comprising of NHS trust hospitals, universities and private healthcare firms--- The Christie NHS Foundation Trust, Northumbria Healthcare NHS Foundation Trust, Northumbria Healthcare NHS Foundation Trust, Great Ormond Street Hospital (GOSH) for Children, CIS Oncology Ltd, Paxman Coolers Ltd, University of Manchester, Cambridgene Ltd, Elsevier Ltd, Cancer Care Commission, Renaissance, TexRad Ltd-- was in Bengaluru from November 9-12 to attend the 2nd Indian Cancer Congress. Mumbai forum is jointly organised by the UK's Department for International Trade, British Deputy High Commission, Mumbai in collaboration with Confederation of Indian Industry (CII)." Full article in below link. http://www.pharmabiz.com/PrintArticle.aspx?aid=105406&sid=2

Hi Horsford, yes 4.25 million traded so far today. Buy / sell ratio is approx 3:1 so any rise should be strong but MM's don't appear to be short of shares yet so price rise remains modest. Real price jump will only come when MM's books are cleared down I reckon. Books must be close to even by now but not quite there yet. Maybe TB is still selling in the background but if so I would have expected more sales. More likely MM's have noticed increase in day traders arriving and will plan a price drop at some point soon if the want to get their shares back at a profit. If price remains steady at this level (or even rises) then it would appear that MM's have no interest in taking today's shares back. That's about all I can come up with for now. As I've said before, I'm a lazy investor and can't be bothered to try and trade much. The share price is significantly below what I believe it should be and will be once TexRAD software is commercialised so I mostly just sit and watch, do a bit of research - TexRAD and Alzheimer's looks particularly interesting long term. Not sure I will be attending the AGM as they are mostly dull affairs but if a few here decide to make the trip it might be nice to put faces to various bulletin board names. I do have a couple of questions I would like answers to but would expect the board to fudge their answers to them.

...this afternoon. 142,331 at 2.0995p, 94,974 at 2.0995p, 93,736 at 2.0995p, 94,952 at 2.1p, 187,895 at 2.115p. Collecting for the end of month statement I suppose.

Evening H, I was completely underwhelmed by the results. AR at least apologised for his earlier misleading remark regarding the CE Mark announcement date but I feel deceived again by the expected "substantial increase in TexRAD-related revenue in the second half of the current financial year and growth in our revenue for the year as a whole" that he talked about last February. A 29% increase in profit isn't bad for the second half of the year but, for a young company with a very exciting healthcare product, I don't think in my wildest dreams I'd call it "substantial". Heck, it didn't even manage a reduction in the overall loss from the previous year. That was up 45%. There are also a couple of other things that bother me in the small print of the Year End report which I will want to mull over for awhile before I post ...or say anything at the AGM. On the plus side, the AGM starts at 3pm this year so I might drag myself up to London and attend, but I'm still not certain it will be worth my effort if the board members, and AR in particular, are planning to short change the shareholders with a load of verbal flannel. Finally, they'd better be certain of obtaining the CE Mark in the next 3 weeks. So close to the end date they should already be 99.9% sure they have it by now. And, if anyone from the Board happens to read this, do not release the CE Mark information on the day of the AGM - it will simply make you look shifty. As if you need that good news on that particular date to cover up a likely heated AGM meeting.

What Alzheimer's does to the brain. Interesting article in today's Independent. http://www.independent.co.uk/life-style/health-and-families/heres-what-we-think-alzheimers-does-to-the-brain-a8039861.html

I think this is the first time I've seen TexRAD being deployed in conjunction with analysis of Alzheimer's disease. https://www.frontiersin.org/articles/10.3389/fnins.2017.00599/full

The latest trade of 237,357 at 1.92p is obviously a sell. They were purchased last Friday afternoon at 2.008p. Someone had a change of mind I guess.

Hi Bob, no such thing as a blue buy these days - as rare as a QPR win at Notts Forest. No info on a results date either. Poor show there. They should be able to provide a date at this late stage. All adds to a sense of unease when there doesn't need to be one. The board need to be far more proactive when it comes to keeping us investors informed.

2p - 2.0175p. The first trade of the day (98,885 at 2.0175p) is a buy.